Ophthalmic research focus grows around glaucoma therapy and device development Webinar spotlight covers BL therapy and ELIOS surgical platform technology Sector discussion expands alongside activity ...

Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.

When the eye's drainage system clogs, pressure builds up and causes damage. The pressure can lead to glaucoma and vision loss. New research, published in the journal Immunity, reveals that a ...

A comanagement program at UCSF in which patients saw glaucoma-trained optometrists and had access to glaucoma specialists showed promising outcomes, according to a study published in Ophthalmology ...

Glaucoma, a leading cause of preventable blindness in South Africa, often goes undetected until it's too late. Discover the crucial steps for early detection and treatment that can save your sight and ...

In studies published so far, GLP-1 receptor agonists appear to be beneficial for the treatment of glaucoma, according to a review published in Cureus.“GLP-1 RAs exert both protective and adverse ...

Glaucoma is an eye disease that damages your eye's optic nerve. Sometimes resulting in permanent vision loss, it's one of the leading causes of blindness in adults over the age of 40. With glaucoma, ...

Whether you’re been experiencing a dull ache, chronic dryness or eye pain that just won’t go away with standard ...

Attendance Allowance or Pension Age Disability Payment provide financial support for people who are severely short-sighted or have eye conditions.

DONGGUAN, GUANGDONG, CHINA, March 10, 2026 /EINPresswire.com/ -- The rapid expansion of smart city infrastructure has ...

According to a recent multi-institute PLOS One study led by the Multisensory Research Lab at the Wilmer Eye Institute, Johns Hopkins Medicine, time of hearing loss onset is a key determinant of ...